Overall mortality of all 80 patients treated for chronic TBAD (Medical vs TEVAR vs Open surgery): both subgroups of patients treated by conventional surgery (Group C vs post-TEVAR group; n = 22) were additionally compared with regard to mortality
| Mortality . | Overall (n = 80) . | Medical (n = 33) . | TEVAR (n = 32) . | Open surgery (n = 15) . | P-value . |
|---|---|---|---|---|---|
| Hospital | 5 (6.3%) | 1 (3.0%) | 2 (6.2%) | 2 (13.4%) | 0.393 |
| 1 year | 9 (11.2%) | 1 (3.0%) | 4 (12.5%) | 4 (26.7%) | 0.054 |
| 3 years | 11 (13.7%) | 1 (3.0%) | 4 (12.5%) | 4 (26.7%) | 0.252 |
| Mortality | Post-TEVAR (n = 7) | Open surgery (n = 15) | P-value | ||
| Hospital | 1 (14.3%) | 2 (13.4%) | 1.000 | ||
| 1 year | 1 (14.3%) | 4 (26.7%) | 0.482 | ||
| 3 years | 1 (14.3%) | 4 (26.7%) | 0.482 |
| Mortality . | Overall (n = 80) . | Medical (n = 33) . | TEVAR (n = 32) . | Open surgery (n = 15) . | P-value . |
|---|---|---|---|---|---|
| Hospital | 5 (6.3%) | 1 (3.0%) | 2 (6.2%) | 2 (13.4%) | 0.393 |
| 1 year | 9 (11.2%) | 1 (3.0%) | 4 (12.5%) | 4 (26.7%) | 0.054 |
| 3 years | 11 (13.7%) | 1 (3.0%) | 4 (12.5%) | 4 (26.7%) | 0.252 |
| Mortality | Post-TEVAR (n = 7) | Open surgery (n = 15) | P-value | ||
| Hospital | 1 (14.3%) | 2 (13.4%) | 1.000 | ||
| 1 year | 1 (14.3%) | 4 (26.7%) | 0.482 | ||
| 3 years | 1 (14.3%) | 4 (26.7%) | 0.482 |
Overall mortality of all 80 patients treated for chronic TBAD (Medical vs TEVAR vs Open surgery): both subgroups of patients treated by conventional surgery (Group C vs post-TEVAR group; n = 22) were additionally compared with regard to mortality
| Mortality . | Overall (n = 80) . | Medical (n = 33) . | TEVAR (n = 32) . | Open surgery (n = 15) . | P-value . |
|---|---|---|---|---|---|
| Hospital | 5 (6.3%) | 1 (3.0%) | 2 (6.2%) | 2 (13.4%) | 0.393 |
| 1 year | 9 (11.2%) | 1 (3.0%) | 4 (12.5%) | 4 (26.7%) | 0.054 |
| 3 years | 11 (13.7%) | 1 (3.0%) | 4 (12.5%) | 4 (26.7%) | 0.252 |
| Mortality | Post-TEVAR (n = 7) | Open surgery (n = 15) | P-value | ||
| Hospital | 1 (14.3%) | 2 (13.4%) | 1.000 | ||
| 1 year | 1 (14.3%) | 4 (26.7%) | 0.482 | ||
| 3 years | 1 (14.3%) | 4 (26.7%) | 0.482 |
| Mortality . | Overall (n = 80) . | Medical (n = 33) . | TEVAR (n = 32) . | Open surgery (n = 15) . | P-value . |
|---|---|---|---|---|---|
| Hospital | 5 (6.3%) | 1 (3.0%) | 2 (6.2%) | 2 (13.4%) | 0.393 |
| 1 year | 9 (11.2%) | 1 (3.0%) | 4 (12.5%) | 4 (26.7%) | 0.054 |
| 3 years | 11 (13.7%) | 1 (3.0%) | 4 (12.5%) | 4 (26.7%) | 0.252 |
| Mortality | Post-TEVAR (n = 7) | Open surgery (n = 15) | P-value | ||
| Hospital | 1 (14.3%) | 2 (13.4%) | 1.000 | ||
| 1 year | 1 (14.3%) | 4 (26.7%) | 0.482 | ||
| 3 years | 1 (14.3%) | 4 (26.7%) | 0.482 |
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
